Diana Langworthy

What's it Worth? A Journal Club Podcast

Scopri le sperimentazioni cliniche e migliora le tue abilità di valutazione delle prove con questo podcast, ideale per studenti e professionisti della salute.

Listen on Apple Podcasts

S3E6 (#22) Twice is Nice! Lenacapavir vs Daily Emtricitabine/Tenofovir for PrEP

S3 E6 • 47 mins • Jun 30, 2025

Charts

This show is not currently ranked in any charts.

Episodi recenti

Jun 30, 2025

S3E6 (#22) Twice is Nice! Lenacapavir vs Daily Emtricitabine/Tenofovir for PrEP

S3 E6 • 47 mins

Jun 3, 2025

S3E5 (#21) Empagliflozin Meets MASLD: Hope, Hype, or Hypothesis?

S3 E5 • 51 mins

May 20, 2025

S3E4 (#20) STOP in the name of eGFR? Continuing vs. stopping ACEi/ARB therapy in ESKD.

48 mins

Apr 23, 2025

S3E3 (#19.2) - Under Pressure! Portal hypertension showdown between carvedilol and classical non-selective beta blockers

S3 E3 • 36 mins

Apr 23, 2025

S3E2 (#19.1) - Seeing the forest for the trees in Hypertrophic Cardiomyopathy with the SEQUOIA Trial

S3 E2 • 28 mins

Lingua
Inglese
Paese
Stati Uniti
Feed Host
Richiedi un aggiornamento
Gli aggiornamenti potrebbero richiedere alcuni minuti.